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Summary 
We have previously demonstrated that human peripheral blood low density mononuclear cells 
cultured in granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4 
develop into dendritic cells (DCs) that are extremely efficient in presenting soluble antigens to 
T ceils. To identify the mechanisms responsible for efficient antigen capture, we studied the endocytic 
capacity of DCs using fluorescein isothiocyanate--dextran,  horseradish peroxidase, and lucifer yellow. 
We found that DCs use two distinct mechanisms for antigen capture. The first is a high level 
of fluid phase uptake via macropinocytosis. In contrast to what has been found with other cell 
types, macropinocytosis in DCs is constitutive and allows continuous internalization of large 
volumes of fluid. The second mechanism of capture is mediated via the mannose receptor (MR), 
which is expressed at high levels on DCs.  At low ligand concentrations, the MR can deliver 
a large number of ligands to the cell in successive rounds. Thus, while macropinocytosis endows 
DCs with a high capacity, nonsaturable mechanism for capture of any soluble antigen, the MR 
gives an extra capacity for antigen capture with some degree of selectivity for non-self molecules. 
In addition to their high endocytic capacity, DCs from GM-CSF+ IL-4-dependent cultures are 
characterized by the presence of a large intracellular compartment that contains high levels of 
class II molecules, cathepsin D, and lysosomal-~issociated  membrane protein-I, and is rapidly accessible 
to endocytic markers. We investigated whether the capacity of DCs to capture and process antigen 
could be modulated by exogenous stimuli. We found that DCs respond to tumor necrosis factor 
or, CD40 ligand, IL-1, and lipopolysaccharide with a coordinate series of changes that include 
downregulation of macropinocytosis and Fc receptors, disappearance of the class II compartment, 
and upregulation of adhesion and costimulatory molecules. These changes occur within 1-2 d 
and are irreversible,  since neither pinocytosis nor the class II compartment are recovered when 
the maturation-inducing stimulus is removed. The specificity of the MR and the capacity to 
respond to inflammatory stimuli maximize the capacity of DCs to present infectious non-self 
antigens to T  cells. 
D 
ifferent mechanisms of antigen uptake are used by differ- 
ent cell types and determine their relative efficiency as 
APCs for MHC class II-restricted T  cells.  Capture of an- 
tigens by surface receptors such as mlg or FcR allows efficient 
delivery of the antigen to the processing compartment via 
receptor-mediated endocytosis (1). Antigens that fail to bind 
to cell surface receptors can still be taken up by fluid phase 
pinocytosis and presented by APCs, but with a much lower 
efficiency. Fluid phase uptake can occur via distinct mecha- 
nisms (2): (a) micropinocytosis, i.e., uptake of small vesicles 
(,,o0.1/zm)  via clathrin-coated pits; and (b) macropinocytosis, 
i.e., uptake of large vesicles (0.5-3 #m) mediated by mem- 
brane ruffling driven by the actin cytoskeleton. While micro- 
pinocytosis occurs constitutively in all cells,  macropinocy- 
tosis  is limited to few cell types, such as macrophages and 
epithelial cells  stimulated by growth factors (3-5). 
Dendritric cells (DCs) 1 play a critical role in antigen pre- 
sentation in vivo since they are the specialized APCs that prime 
virgin T  cells (6).  A  large body of evidence from ex vivo 
experiments indicates that the capacity to interiorize and pro- 
cess antigen is a constitutive property of immature DCs present 
1 Abbreviations used in this Faper: AML, amiloride; CCD, cytochalasin  D; 
CD40L, CD40 ligand; DC, dendritic cell; DMA, 5-(N,N-dimethyl)- 
amiloride;  DX, dextran; HRP, horseradish  peroxidase;  Lamp-l,  lysosomal- 
associated membrane  protein; LY, lucifer  yellow;  MK, mannose  receptor. 
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DCs, after in vivo antigenic challenge, move to the T  cell- 
dependent areas of secondary lymphoid organs (6). It is also 
lost spontaneously when immature DCs such as Langerhans 
cells are cultured in vitro (7, 8). For these reasons, it has been 
difficult to characterize the mechanisms of antigen uptake 
by DCs. In particular, it is not clear whether DCs have high 
endocytic capacity and whether they may have  specialized 
receptors for the capture of foreign antigens. 
We have recently described an in vitro culture system using 
GM-CSF and IL-4 that permits DCs to be maintained in a 
state where they are competent for antigen capture and pro- 
cessing (9). Such cultured DCs present a soluble antigen taken 
up by fluid phase as efficiently as antigen-specific B cells that 
can use mlg for its capture via receptor-mediated endocy- 
tosis. Strikingly, stimulation with TNF-ot results in an inhi- 
bition of the capacity to present a soluble antigen and, at 
the same time, an increase in T cell stimulatory capacity (9). 
To understand the basis of the extraordinarily efficient an- 
tigen presentation, we have analyzed the mechanism of an- 
tigen capture by these cultured DCs.  Here we report that 
DCs express the MR and use it for efficient capture of a va- 
riety of antigens. In addition, DCs are characterized by a very 
high level of macropinocytosis that allows them to take up 
large amounts of fluid and concentrate the macrosolutes in 
a compartment that contains MHC class II molecules and 
proteases.  TNF-c~, as well as inflammatory stimuli, induce 
coordinate and irreversible changes that result in loss of the 
capturing machinery and a simultaneous increase in T  cell 
stimulatory capacity. 
Materials and Methods 
Media and Reagents.  The medium used throughout was RPMI 
1640 supplemented  with 2 mM t-glutamine, 1% nonessential  amino 
acids, 1% pyruvate, 50 #g/ml kanamycin (Gibco, Grand Island, 
NY),  5  x  10 .5 M 2-ME (Merck, Darmstadt,  Germany), and 
10% FCS (Hyclone  Laboratories,  Logan, Utah). Human rib2, rIL-4, 
and rGM-CSF were produced in our laboratory by PCR cloning 
and expression in the myeloma expression system (10). IL-4 and 
GM-CSF concentrations were determined using commercial  ELISA 
assays. Human recombinant TNF-ce, TNF-ce  with point mutations 
at residues 32 and 86 (Trp32-Thr86-TNF-ce, specific  for TNF-R55), 
and TNF-cr with point mutations at residues 143 and 145 (Asn143- 
Arg145-TNF-ce, specific for TNF-R75)  (11) were a generous gift 
from Dr. W. Lesslaner  (Hoffmann-La Roche, Basel, Switzerland). 
Human rlLloe and rlbl~ were gifts from Dr. L. Melli (IRIS, Siena, 
Italy). Ib6 was a kind gift from Dr. T. Rolink (Basel Institute for 
Immunology, Basel, Switzerland). Lucifer yellow CH, potassium 
salt,  FITC-transferrin,  and  lysine-fixable FITC-dextran,  M,  = 
40,000, were  purchased from Molecular Probes, Inc. (Eugene, OR) 
as lyophilized  powder, reconstituted  in PBS, and spun in a microfuge 
before use to eliminate aggregates. Horseradish peroxidase (HRP), 
o-phenylendiamine dihydrochloride,  diaminobenzidine,  FITC- 
mannosylated BSA, mannan from Saccharomyces cerevisiae, amylo- 
ride (AML), 5-(N,N-dimethyl)-amyloride (DMA), cytochalasin  D 
(CCD), and LPS from Escherichia coli were purchased from Sigma 
Immunochemicals  (St. Louis, MO). J558 myeloma  cells transfected 
with CD40L were kindly provided by Dr. P. Lane (Basel Institute 
for Immunology). 
Cells.  The method for the in vitro culture of human DCs has 
been described (9). Briefly,  PBMC obtained by the standard Ficoll- 
paque method (Organon Teknika, Durham,  NC) were separated 
on multistep Percoll gradients (Pharmacia Fine Chemicals, Upp- 
sala, Sweden) and the light density fraction from the 42.5-50% 
interface was recovered and depleted of CD19 § and CD2 § cells 
using magnetic beads coated with specific  antibodies (Dynal, Oslo, 
Norway). The remaining cells were cultured at 3  x  10S/ml in 
RPMI-10% FCS supplemented  with 50 ng/ml GM-CSF and 1,000 
U/ml IL-4 at 37~  at 5% COs in air. DCs were used routinely 
from 8 to 15 d of culture. EBV-transformed  B cell lines and T cell 
clones were obtained and maintained as previously  described (12). 
To obtain human macrophages, monocytes were separated from 
PBMC using a single-step (43%) Percoll gradient and were cul- 
tured for 10 d in Teflon-coated  petri dishes (Heraeus, Zfirich, Switz- 
erland) in Hepes-buffered  RPMI 1640 supplemented with 2 mM 
t-glutamine and 50% heat-inactivated  human serum. Mouse mac- 
rophages were obtained by washing the peritoneal cavity with cold 
PBS. Human fibroblast  MRC-5 was obtained from American Type 
Culture Collection (Rockville, MD). The MonoMac cell line was 
kindly  provided by Dr.  G.  Riethmuller  (Munich  University, 
Munich, Germany). Veiled cells from the afferent lymph of sheep 
were provided  by Dr. Wayne  Hein (Basel  Institute for Immunology). 
Staining with mAbs.  Cell staining was performed using mouse 
mAbs followed by  FITC-  or  PE-conjugated, affinity-purified, 
isotype-specific goat  anti-mouse  antibodies (Southern Biotech- 
nology, Birmingham, AL). The following mAbs were used: L243 
(IgG2a, anti-DR), W6/32 (IgG2a, anti-MHC class I), IV.3 (IgG2b, 
anti-CD32), SPVL3 (IgG2a, anti-DQ)  (all from American Type 
Culture Collection), B7.24 (IgG2a, anti-CD80 was provided by 
Dr. Mark Deboer, Immunogenetics, Ghent,  Belgium), R/R1.1 
(IgG1, anti-CD54), TS2/9 (IgG1, anti-CD58) (both provided by 
Dr. T. Springer, Harvard Medical School, Boston, MA), LeuM3 
(IgG2b, anti-CD14; Becton Dickinson Immunocytometry Systems, 
Mountain View, CA), G28.5 (IgG1, anti-CD40, provided by Dr. 
A. E. Clark, University of Washington, Seattle, WA), Tul (IgG3, 
anti-CD23, provided  by Dr. A. Ziegler, University  of  Berlin, Berlin, 
Germany), and 3.29 (IgG1, anti-MR; Cella, M., unpublished  data). 
The samples were analyzed on a FACScan  |  (Becton Dickinson) 
using propidium iodide to exclude dead cells. 
Quantitation of  Endocytosis in Single Cells by FACS~ Analysis.  Cells 
were resuspended  in 10% FCS medium buffered  with 25 mM Hepes 
at 37~  FITC-DX or LY were added at the final concentration 
of 1 mg/ml if  not otherwise indicated for different times. The cells 
were washed four times with cold PBS containing 1% FCS and 
0.01% NaN3 and were analyzed on a FACScan  |  (Becton Dick- 
inson) using propidium iodide to exclude  dead cells. The background 
(cells pulsed at 0~  was always subtracted. In some  experiments, 
the cells were pulsed  at 37~  washed  four times with cold medium, 
and cultured at 37~  for different times in marker-free medium. 
CCD, AML, and DMA were added to the cell suspension at 37~ 
15 rain before the addition of the marker. The amount of fluores- 
cent probe accumulated was calculated from the FITC to probe 
ratio with reference  to a standard  curve  of  beads labeled  with known 
amount offluorescein (Flow Cytometry  Standard Corp., Research 
Triangle Park, NC). 
Quantitation of Endocytosis in Bulk Populations.  DCs were in- 
cubated at 37~  in the presence of  different concentration of HRP. 
At various times, the cells were collected, washed four times in 
PBS containing 1% FCS and four times in PBS alone with one 
tube change, lysed with 0.05% Triton X-100 in 10 mM Tris buffer, 
pH 7.4, for 30 rain, and the enzyme activity of the lysate was mea- 
sured using o-phenylendiamine and H202 as substrates with ref- 
390  Mechanisms  of Antigen Uptake by Dendritic Cells erence to a standard curve. In other experiments, DCs were incu- 
bated with different concentrations of FITC-DX or LY, treated as 
described above, and the fluorescence of the lysate was measured 
with an  automated  fluorimeter (Titertek  Fluoroskan II;  Flow 
Laboratories, UK) with reference to a standard curve. The cell ly- 
sate did not interfere with the quantitation of the fluorochrome. 
Identification of Macropinosomes by HRP.  To visualize HRP up- 
take, the cells were incubated with 1 mg/ml HRP, washed with 
cold medium, and cytospun onto coverslips in a cytocentrifuge. 
The cells were fixed in 1% paraformaldehyde +  1.7% glutaralde- 
hyde in 0.1 M Na-cacodylate buffer, pH 7.4, for 12 min, washed 
four times in Na-cacodylate  buffer, and the enzymatic reaction was 
developed using 1 mg/ml diaminobenzidine and 0.01% HzO2 in 
Na-cacodylate buffer. 
Confocal Microsco~.  Cells  were adhered to glass slides (Poly- 
science; Miles Inc., Kanakee,  IL) coated with 50 #g/ml poly-t-lysine 
(Sigma), fixed in 2% paraformaldehyde  in Ca +  +/Mg +  +-free PBS, 
and quenched by washing with 50 mM ammonium chloride. Cells 
were permeabilized  in PBSAaponin (0.01%)/gelatin (0.25%)/NP-40 
(0.1%) and were sequentially  incubated with different  primary anti- 
bodies followed  by isotype- or species-specific  Texas red- or FITC- 
labeled secondary antibodies (Southern Biotechnology Associates, 
Birmingham, AL). The following primary antibodies were used: 
L243 (anti-DR, mouse IgG2a; American Type  Culture Collection), 
anti-human cathepsin D (rabbit antisera, a generous gift from Dr. 
S. Kornfeld, Washington University, St. Louis, MO), anti-human 
Lamp-1 (rabbit antisera, a generous gift from Dr. S. Carlsson, Umea 
University, Sweden). Slides were mounted in 90% glycerol/PBS 
containing 2.5%  DABCO (1-4-diazabicyclo[2.2.2]octane; Fluka 
Chemie AG, Buchs, Switzerland) to minimize photobleaching and 
were analyzed with a confocal laser scanning microscope system 
(MRC-600; Bio Rad Laboratories, Hercules, CA) attached to a mi- 
croscope (Axiovert 35M; Carl Zeiss, Inc., Thornwood, NY). Ap- 
propriate controls were always  included and bleedthrough correc- 
tions were done according to the manufacturer's recommendations 
and were tested in a single-labeling experiments. To visualize the 
relative  positional  distribution of  the two fluorochromes,  the images 
collected in the two channels were merged. To combine a three- 
dimensional  z series into a two-dimensional  image, 26 sections span- 
ning the entire cell were projected and superimposed. 
Reslllts 
Dissection of Fluid Phase and Receptor-mediated Endocytosis 
in DCs.  We have studied the endocytic capacity of  DCs using 
three classical markers: LY, FITC-DX, and HRP. While HRP 
could be used only to quantitate uptake in bulk populations, 
FITC-DX and LY also allow quantitation at the single-cell 
level by FACS  |  analysis. A typical experiment (Fig. 1 A) shows 
that DCs incubated at 37~  with FITC-DX accumulate this 
marker in a time-dependent fashion. The narrow distribu- 
tion of the fluorescence profile indicates that all cells take up 
comparable amounts of the probe. On the contrary, EBV-B 
cells were dishomogeneous since only a small percent of the 
cells take up FITC-DX, and only in a much lower amount 
(Fig.  1 B). In addition, EBV-B cells do not accumulate the 
marker. Similar results were obtained with LY (see below). 
As shown in Table 1, the efficient accumulation of FITC- 
DX and LY is a peculiar property of cultured DCs and veiled 
cells freshly isolated from sheep afferent lymph, which is not 
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Figure 1.  Accumulation  of FITC-DX in DCs. DCs grown in GM- 
CSF + IL-4  (A) or EBV-B cells (B) were incubated  in medium  containing 
1 rag/m1  FITC-DX  for various  times,  washed, and analyzed  on a FACScan  | 
The  fluorescent stainings cannot be  compared since much lower 
amplification was used for DCs than for EBV-B cells. 
shared by other cell types analyzed, such as macrophages, 
monocytes, fibroblasts,  lymphocytes, and various cell lines. 
This property is not lost when DCs are cultured in medium 
without GM-CSF and IL-4 for up to 5 d, making it very 
unlikely that the pinocytosis is dependent on stimulation by 
exogenous factors. Taken together, these results suggest that 
the high rate of endocytosis in DCs is constitutive. 
A  quantitative analysis of uptake of LY, FITC-DX, and 
HRP by DCs is shown in Fig. 2.  All markers accumulate 
in a linear fashion with time.  Upon chase in marker-free 
medium, FITC-DX is completely retained for long periods 
of time (up to 10 h, data not shown), while HRP and LY 
are lost to a variable extent ('~50% in 1 h), possibly because 
they are degraded or released and thus will underestimate the 
amount taken up during prolonged incubations. 
While fluid phase uptake is not saturable, uptake via specific 
receptors  is saturable  with increasing concentrations of the 
ligand. To get information about the mechanisms of uptake 
of the different markers, we measured the amount of marker 
taken up as a function of the concentration in solution. While 
the amount of LY accumulated by DCs was proportional to 
the concentration of  LY in the medium, the amounts of  FITC- 
DX and HRP showed a clear saturation at increasing doses 
of the marker. Thus, while LY behaves as a bona fide fluid 
391  Sallusto  et al. Table  1.  Fresh  and Cultured DCs Have a High and Constitutive 
Capacity to Accumulate Fluid Phase Markers 
Median  fluorescence  intensity: 
LY*  FITC-DX* 
7min  30min  7  rain  30rain 
DC  (GM -  CSF + IL-4)  408  1494  780  3290 
DC  no  cytokinest  -  -  501  2229 
Sheep  veiled  cells  60  150  456  1905 
Fresh  monocytes  -  -  32  19 
Cultured  macrophages  -  -  67  71 
Mouse  macrophages  --  --  16  35 
MonoMac  17  58  11  12 
EBV-B  19  50  19  11 
T  cell  clone  13  31  0  0 
* Cells were incubated with 1 mg/ml FITC-DX or LY for 7 or 30 min 
at 37~  washed four times, and analyzed using the same amplification 
conditions. The mean fluorescence  intensity is shown. The background 
fluorescence  (cells  incubated  at 0~  for  30 rain)  was subtracted. 
* DCs from GM-CSF + IL-4 cultures were washed and recultured in the 
absence of GM-CSF and  IL-4  for  5  d  before  the assay. 
phase marker, FITC-DX and HRP appear to be taken up 
by a saturable mechanism, implying the existence of a specific 
receptor. 
Identification of the Mannose Receptor (MR) as the Major 
Receptor  for Endocytosis of FITC-DX and HRP in DCs.  We 
have recently produced an mAb to the human mannose recep- 
tor by immunizing mice with cultured DCs. This antibody 
stains both cultured DCs and DCs in tissue sections of both 
human and sheep. It also stains hepatic  sinusoidal cells and 
scattered cells in the thymus. It also precipitates a 175-kD 
molecule from DC and inhibits uptake of mannosylated BSA 
(Cella, M., et al., manuscript in preparation). To test whether 
the putative receptor for FITC-DX is the MR, we measured 
FITC-DX uptake in the presence or absence of mannan,  a 
bacterial polysaccharide that binds with high a~nity to the 
MR.  As  shown in  Fig.  3 A,  mannan  inhibits  uptake  of 
FITC-DX in a dose-dependent  fashion.  Maximum inhibi- 
tion is reached at 0.3 mg/ml and does not further increase 
at higher concentrations of mannan. The inhibition of FITC- 
DX uptake is not complete and the noninhibitable  compo- 
nent shows a linear increase with increasing concentrations 
of the marker, indicating that,  in the presence of mannan, 
the uptake of the FITC-DX takes place by the fluid phase 
(Fig.  3 B). 
To further investigate the role of MR in DC endocytosis, 
we tested  the inhibitory effect of EDTA and specific anti- 
MR antibody on uptake of the three markers. As shown in 
Fig. 4, the uptake of FITC-DX and HRP was inhibited  to 
a comparable extent by EDTA,  mannan,  and anti-MR anti- 
body, while the same treatments  did not affect the uptake 
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Figure  2.  Endocytosis of different markers in DCs reveals saturable and 
nonsaturable mechanisms  of uptake. (A-C) DCs were incubated with 1 
mg/ml LY (0),  FITC-DX (A), or HRP (ll) at 37~  At various time 
points the cells were washed in cold medium and the amount of ligand 
accumulated was measured. (D-F) DCs were pulsed for 15 rain with LY 
or FITC-DX or for 30 min with HRP, washed with cold medium, and 
analyzed  immediately or  after culture  for various  times in marker-free 
medium. (G-/) DCs were incubated at 37~  in the presence of different 
concentration  of LY, FITC-DX,  or HRP, and the amount accumulated 
was measured after 30 min (G-H)  or 1 h (/).  When the markers were 
used at I mg/ml, the uptake after incubation for 30 min at 0~  was <1% 
of the uptake at 37~  for LY and HRP and <2% for FITC-DX. 
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Figure  3.  The inhibitory effect of mannan reveals saturable and non- 
saturable components in the uptake of FITC-DX by DCs. (A) DCs were 
incubated at 37~  in the presence or absence of different concentrations 
of mannan, and after 10 min, FITC-DX was added at the final concentra- 
tion of 2 (O),  1 ([~), or 0.4 (A) mg/ml. The data show the fluorescence 
of the cells after 30 min. (B) Amount of FITC-DX taken up in the absence 
(&)  or in the  presence  (O)  of 3  mg/ml mannan  as a function of the 
FITC-DX concentration  in the medium. 
392  Mechanisms  of Antigen Uptake by Dendritic Cells Figure  4.  The MR is the major receptor for endocytosis of FITC-DX 
and HRP. DCs were incubated at 37~  in normal medium or in medium 
containing anti-MR  antibody or 3 mg/ml mannan, or in PBS-10% dia- 
lyzed FCS containing 0.5 mM EDTA. After 10 rain, FITC-DX (black bars), 
HRP (grey bars), or LY (stippled  bars), all at 1 mg/ml, were added. The 
uptake was measured after 15 min and expressed as percent of the uptake 
in medium alone. 
of LY.  Thus  ligand  specificity,  calcium  dependency,  and  a 
specific antibody identify MR as the most important if not 
the exclusive receptor involved in endocytosis  of FITC-DX 
and  HRP  by DCs. 
Quantitation  of Marker  Taken  up via MR  and Fluid Phase. 
Table 2  shows  an estimate  of the  amount  of marker  taken 
up by DCs by fluid phase or MR`-mediated uptake. Fluid phase 
uptake was measured using LY or FITC-DX in the presence 
of inhibitory  concentrations  of mannan.  We estimate  that 
a  single DC  can  take up every hour  an amount  of marker 
corresponding  to  a  volume  of  1,000-1,500  /zm  3.  These 
volumes, which are probably underestimated because of losses, 
are close to  the volume of the cell itself.  The fact that  the 
markers are present in a discrete cellular compartment indi- 
cates  that  DCs  must  be  able  to  concentrate  the  markers. 
Uptake via the MR was quantitated using ligands that bind 
to the MR (FITC-DX, FITC-mannosylated BSA, and HRP). 
As  shown  in  Table 2,  the  MR  allows  DCs  to  accumulate 
a large number of molecules per cell, even at low concentra- 
tions of the ligand.  The number of molecules  taken up via 
the MR exceeds the number of MR. per cell, indicating that 
the receptor can be used in successive rounds of binding,  in- 
ternalization,  and  delivery. 
Evidence for Macropinocytosis by DCs In  Vitro and In  Vivo. 
The very high level of fluid phase uptake in DCs prompted 
us to search for the responsible mechanism.  Morphological 
examination of DCs pulsed for very short times with various 
markers revealed the  formation  of large numbers  of struc- 
tures resembling macropinosomes. Macropinosomes could be 
detected  as early as 30  s after addition  of HRP  (Fig.  5 A), 
their number increased with time at 37~  for the first 2-3 
min. The size of the macropinosomes varied from 0.5 to 3/~m 
in diameter (mean  =  1/~m) in different cells, but was rather 
homogeneous in each individual cell. Similar results were ob- 
tained using HR`P (Fig.  5, A  and B),  FITC-DX  (Fig.  5,  C 
and D),  and LY (Fig.  5 E).  Interestingly,  similar structures 
were observed to form when freshly isolated veiled cells from 
sheep afferent lymph were incubated  with  FITC-DX  (Fig. 
Table  2.  Amount of Molecules Accumulated per Hour by Fluid Phase or MR-mediated Uptake in a Single DC 
Molecules/cell  Equivalent 
Marker concentration  per hour  volume (#m3) II 
LY (2  x  10-3M)  *  1.1-1.3  ￿  109  920-1100 
FITC-DX  (2.5  x  10 -5 M+mannan)*  14-22  x  106  930-1500 
FITC-DX  (2.5  ￿  10 -8 M)*  300,000  20,000 
FITC-BSA-Mann.  (10 -s M)*  2,200,000  366,000 
FITC-BSA-Mann.  (10 -9 M)  440,000  733,000 
HRP  (4  x  10 -7 M)  s  24,000,000  100,000 
HRP  (8  x  10 -8  M)  14,200,000  296,000 
HRP  (1.6  x  10 -8 M)  4,600,000  478,000 
HtLP  (3.2  x  10 -9 M)  1,050,000  547,000 
HRP  (6.4  x  10 -1~ M)  240,000  625,000 
HRP  (1.3  x  10 -1~ M)  66,000  860,000 
HRP  (2.6  x  10 -11 M)  13,500  877,000 
* The amount  of marker was measured in cell lysates using a fluorimeter by reference to a standard curve. The cell lysate did not interfere with 
the quantitation  of the marker.  Data  are from two separate experiments. 
The amount of marker was measured by cytofluorimetric analysis on the basis of the FITC content of the marker by reference to a standard curve 
of beads containing  known amounts of FITC. 
S The amount  of marker  was measured in cell lysates by reference to a standard curve of HRP. 
LI Equivalent volume corresponds to the volume of fluid that contains the amount of marker accumulated in the cell. The volume of a DC was ~2,500 
/gin  3,  as determined by hematocrit. 
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somes in DCs in vitro and in vivo.  DCs were  incubated 
for 30 s (A) or 1 min (B) with 1 mg/ml HKP, washed 
in cold  medium, fixed,  and the enzymatic  reaction  was 
developed.  Bar, 20 #m. Unpulsed  cells  or cells  incubated 
for the same times  at 0~  were  completely  negative  (not 
shown). DCs were  incubated  with I mg/ml FITC-DX 
for 1 min (C) or 3 rain (/9) at 37~  washed in cold 
medium, fixed,  and analyzed  by taking the z series  using 
a confocal  microscope.  Each  image results from projec- 
tion of 26 sections.  DCs were  incubated  with I mg/ml 
LY at 37~  for 2 min (E), washed  in cold  medium, and 
analyzed  as above.  Cells from  sheep  afferent  lymph  were 
pulsed for 5 min with 1 mg/ml FITC-DX, sorted ac- 
cording  to physical  parameters,  and analyzed  as described 
above (F). 
5 F). Macropinosomes were difficult to visualize under phase 
contrast because the cells are not adherent. 
Macropinocytosis is dependent on membrane ruffling and 
has been reported to be inhibitable by CCD (4), AML (13), 
and DMA (Watts, C., personal communication). As shown 
in Fig. 6, uptake of LY and FITC-DX is inhibited by these 
three drugs while the same drugs have a much lower effect 
on uptake of FITC-transferrin by EBV-B cells, which occurs 
only by endocytosis mediated by the transferrin receptor. In 
all cases, inhibition by DMA was completely reversed 5 min 
after removal of the drug  (data not  shown). 
Taken together, these results indicate that macropinocy- 
tosis is a constitutive function of both in vitro-cultured and 
fresh DCs. 
Macropinosomes  Deliver  their Content to a Large Compartment 
that Contains  MHC Class II, Cathepsin  I~ and Lysosomal-associated 
Membrane Protein-I (Lamp-l).  DCs grown in GM-CSF  + 
IL-4 were fixed, permeabilized, and stained with antibodies 
to mature class II molecules and cathepsin D  or Lamp-1. As 
shown in Fig.  7, mature class II molecules were present on 
the cell surface and in an extensive intraceUular compartment. 
This compartment contains also  cathepsin D  and Lamp-1 
(yellow structures in Fig.  7, A  and B). 
To establish whether this class I! compartment might be 
reached by fluid phase markers, DCs were pulsed with FITC- 
DX for 2 min at 37~  and examined either immediately or 
after a chase at 37~  for 15 min. 2 min after pulsing, FITC- 
DX was present in a large number of macropinosomes as 
a ring at the periphery of the cell (Fig. 8 A, green structures), 
which did not colocalize with intraceUular class II molecules 
(Fig.  8 A,  red structures) or cathepsin D  (data not shown). 
When DCs pulsed with FITC-DX were chased in marker- 
free medium,  the green fluorescence became redistributed 
throughout the cell in what appeared as a large tubular and 
vesicular network. After 10-15 rain of chase,  we observed 
an extensive colocalization of FITC-dextran with class II mol- 
ecules  (Fig.  8 B),  cathepsin D,  and Lamp-1  (not  shown). 
Downregulation of Macropinocytosis and Disappearance of the 
MHC Class II Compartment  Induced  by TNF-o6 CD4OL, IL-1 
and LPS.  We have used GM-CSF  +  IL-4-dependent DCs 
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DCs to identify the signals responsible for DC maturation. 
As likely candidates,  we tested the effect of various cytokines 
that may be present at  the site of inflammation  and a bac- 
terial  product  such  as LPS. 
The effects of these stimuli on the endocytic capacity  of 
DCs is  shown in Fig.  9.  Incubation with TNF-ot for 40 h 
resulted in a marked downregulation of the uptake of FITC- 
DX. Using mutant TNF-tx molecules that interact selectively 
with the p55 or the p75 receptors,  we found that this inhibi- 
tory effect is entirely mediated via the p55 receptor.  The in- 
hibitory  activity  of TNF-ot was lost  after boiling  and was 
blocked by a specific antibody to TNF-tx, ruling out the pos- 
sibility that other contaminants may be responsible for this 
effect. In addition to TNF-tx, preincubation with IL-lfl and 
cell-bound CD40L resulted in a similar inhibitory effect. LPS 
was also effective in downregulating pinocytosis. In this case, 
Figure  6.  Inhibition of LY and FITC-DX uptake by drugs that affect 
macropinocytosis. Uptake of FITC-DX (1 mg/ml) (A) or LY (1 mg/ml) 
(B) by DCs in the presence of various drugs. Uptake of FITC-transferrin 
(1 /zg/ml) by EBV-B cells in the presence of the same drugs (C).  The 
drugs were added at 37°C 15 min before the addition of the marker. The 
results are expressed as percent of the uptake in the absence of inhibitors. 
The vehicle did not show any effect. 
Figure  7.  DCs have a large class II compartment that 
colocalizes  with cathepsin D  and Lamp-1. DCs were 
fixed,  permeabilized,  and  stained  by  indirect  im- 
munofluorescence. (A) DR (green),  cathepsin D  (red); 
(B)  DR  (green)  Lamp-1 (red).  When red  and green 
staining  overlap, the compartment appears yellow. 
Figure  8.  The content of macropinosomes is deliv- 
ered to the MHC class II compartment. DCs were pulsed 
with FITC-DX  for 2 min and analyzed immediately 
(A) or after a 15-min chase in marker-free medium (/3). 
The cells were fixed, permeabilized, and stained with 
anti-DR (L243) followed by Texas red-labeled  second 
antibody. 
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did  not  show  formation  of  macropinosomes  even  after 
prolonged incubation (Fig.  10 A).  The same treatment in- 
duced a disappearance of the class II compartment, as well 
as of the cathepsin-D-positive organelles (Fig.  10 B).  Sur- 
prisingly, the loss of the class II compartment was not ac- 
companied by a reduction in class II synthesis, which was 
actually transiently increased after treatment with TNF-ot 
(SaUusto,  F.,  unpublished results). 
When  compared  to  untreated  cells,  cells  treated  with 
TNF-o~ or LPS showed an increased expression of class II 
and class I molecules, B7.1 (CD80), LFA3 (CD58), and intra- 
cellular adhesion molecule 1 (CD54), as well as a decreased 
expression of FcR (CD32 and CD23) (Fig. 11). Interestingly, 
the expression of MR was reduced by less than 50%. These 
coordinate changes were observed in all the 10 different cell 
lines tested. The most striking induction was observed with 
TNF-o~ and LPS, while a lower effect was seen with IL-1/3. 
The maturation-inducing effects of TNF-o~ and LPS are irre- 
versible since  neither pinocytosis nor the class II compart- 
ment were recovered, even several days after removal of the 
inducing stimuli. 
Figure 9.  In DCs pinocytosis  is downregulated  by TNF°c~, CD40L, 
Iblfl, and LPS. DCs from GM-CSF + Ib4-dependent  cultures  were in- 
cubated for 40 h with various stimuli and the uptake of FITC-DX (A), 
HRP (/3), and LY (C), all at 1 mg/ml, were measured after 30 min of 
pulse. TNF-c~  was added at 20 ng/ml, TNF-c~  mutants that interact only 
with the p55 or with the p75 TNF receptors  at 200 ng/ml, IL-lfl  at 104 
U/ml, and LPS at 20 ng/ml. Irradiated  J558 calls transfected  with CD40L 
were added at a 1:1 ratio and were gated out during the acquisition  using 
an anti-DR antibody  to identify  DCs. Rabbit anti-TNF-ol  antiserum or 
normal rabbit serum were added together with the inducing stimuli. 
the effect was not inhibited by boiling nor by an anti-TNF-c~ 
antibody, indicating that LPS does not act indirectly via in- 
duction of TNF-c¢ production (Fig.  9 A). A similar inhibi- 
tion of uptake was observed using HRP (Fig. 9 B), as well 
as LY (Fig.  9 C), suggesting that these stimuli decrease both 
fluid phase-  and receptor-mediated uptake. 
Discussion 
We have previously demonstrated that human DCs from 
GM-CSF  +  IL-4-dependent cultures are highly e~cient in 
presenting soluble antigens and that they lose this capacity 
when treated with TNF-c~ (9). Here we provide an explana- 
tion for both findings.  First, we show that DCs have two 
specialized mechanisms for antigen capture: the MR and mac- 
ropinocytosis that allow them to take up and concentrate mac- 
romolecules in the MHC class II compartment. Second, we 
show that inflammatory cytokines and bacterial products in- 
duce a coordinate and irreversible change in DCs with loss 
of macropinocytosis and disappearance of the class II com- 
partment and upregulation of adhesion and costimulatory 
molecules. We discuss these results in the context of the model 
of DC maturation (6). 
Antigen  Capture  via  MR.  The MR. is a surface 175-kD 
C-type lectin containing eight carbohydrate recognition do- 
Figure  10.  Macropinosomes  and the class II compart- 
ment disappear  after  TNF-a treatment. DC maturation 
was induced by 20 ng/ml TNF-c~ for 40 h. (A) The 
cells were incubated with 1 mg/ml FITC-DX (green) 
for 30 min and subsequently  stained with anti-DR an- 
tibody  (red)  as in Fig. 8. (B) The calls  were  stained  with 
anti-DR (green) and anti-cathepsin  D (red) as in Fig. 7A. 
396  Mechanisms  of Antigen Uptake by Dendritic Cells N  C  HLA-DR  HLA-DQ  class-I  MR  CD14 
!IA,  t  ,,.A'I 
"A  ).  a!..,i! 
B 
C 
CD80  CD40  CD58 
A 
IA 
.....  1311"  "-  ~  i~ 
i1_ A 
I  A 
IP  ~  I~  13P  Ib" 
CD54  CD32  CD23 
Figure  11.  Changes in cell surface phenotype induced by treatment of DCs with TNF-oz or LPS. DCs untreated (A) or treated with 20 ng/ml 
TNF-oz (B) or 20 ng/ml LPS (C) for 40 h were stained with different mAbs. The first panel (NC) shows the profile obtained using an isotype-matched 
control antibody. 
mains with broad specificity for sugars (14). It mediates phago- 
cytosis of mannose-coated particles such as yeasts and endocy- 
tosis of mannosylated glycoproteins in macrophages (15). So 
far,  MR has been demonstrated  only on scavenger macro- 
phages. Its presence on DCs has been suggested on the basis 
of their capacity to phagocytize yeast particles (16). 
We have identified the MR as the major receptor respon- 
sible for endocytosis of HRP and FITC-DX in DCs. This 
conclusion is based on the observation that uptake of these 
markers is saturable and can be inhibited by mannan, EDTA, 
and by an antibody to the human MR. Using this antibody, 
we have demonstrated that the MR is expressed in cultured 
DCs, and we have evidence that it is also expressed on DCs 
in vivo, as detected by staining of tissue sections (Celia, M., 
et al.,  manuscript  in preparation). 
There are two features of the MR that  are crucial for its 
function  in  antigen  presentation:  (a)  the  broad  ligand 
specificity; and (b) the capacity to release  the ligand at low 
pH and recycle after delivery of the ligand. 
MR is known to bind various types of sugars such as man- 
nose, fucose, and N-acetyl-glucosamine, as well as hydrophobic 
molecules (14).  It is possible that even very low a~nity in- 
teractions may be su~cient to allow adsorptive endocytosis 
via the MR.. Thus, MR can be viewed as a pattern recogni- 
tion molecule that can provide DCs with some capacity of 
self non-self discrimination at the level of antigen uptake on 
the basis of glycosylation and perhaps hydrophobicity. It will 
be interesting to see whether self proteins released by lysed 
cells in the high mannose form may be captured and presented 
with high efficiency by DCs. 
The second important  feature of the MR is the capacity 
to release its ligand at low pH and recycle to the cell surface 
(17). In this way, the MR can deliver ligands in consecutive 
rounds and thus in amounts that far exceed the number of 
receptors (see Table 2). Indeed, the amount of FITC-DX and 
HRP bound to DC at 0~  is only '~1% of the amount taken 
up in 30 rain at 37~  This is at variance with mIg or FcR, 
which  do  not  dissociate antigen  at  low pH  and  are  thus 
degraded together with their cargo (18, 19). Thus, while mlg 
and FcR offer a limited capacity for antigen capture, the MR 
offers an unlimited  capacity to accumulate  antigen. 
The  presence  of the  MR  on  DCs  suggests  that  man- 
nosylated antigens or toxins can be targeted in vivo to DCs 
to enhance immunogenicity or to deplete DCs from tissue 
grafts. 
Macropinocytosis.  Macropinocytosis has been characterized 
in epithelial cells and macrophages as a cytoskeleton-dependent 
mechanism  of fluid  uptake  induced  by  stimulation  with 
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tosis, which occurs via clathrin-coated pits (3-5). While the 
importance of micropinocytosis in the capture of membrane- 
bound  ligands  has  been  well  recognized,  the  functional 
significance of macropinocytosis has been an unresolved issue. 
Our results point to a specialized function for macropinocy- 
tosis in DCs, i.e., volume capture and solute concentration 
in the class II compartment. 
We have shown that DCs are characterized by a very high 
level of fluid endocytosis, as measured by the uptake of LY, 
which behaves as a pure fluid phase marker, or by the uptake 
of FITC-DX in the presence of concentrations of mannan 
that inhibit MIk-mediated uptake. The fluid volume taken 
up per hour by a single DC has been estimated to be 1,000- 
1,500/zm 3, a volume that is close to that of the cell itself. 
This clearly indicates that these cells are able to concentrate 
the marker in a discrete intracellular compartment. 
The evidence for macropinocytosis in DCs is based on mor- 
phological criteria and sensitivity to inhibitory drugs. As early 
as 30 s after addition of the marker, several macropinosomes 
measuring 0.5-3 #m in diameter are formed in DCs and their 
number increases to '~100 at 1 min. The uptake of '~100 
pinosomes of'~l/zm diameter would account for a fluid up- 
take of 50 #m3/min and therefore m3,000 ~mZ/h, a figure 
that would be compatible with that estimated using fluid 
phase markers. This type of calculation would require a more 
careful stereological analysis  (20). 
In these cultured DCs, the level of macropinocytosis is much 
higher than in other cell types (4,  5),  probably because of 
the very active membrane ruffling. In addition, while mac- 
ropinocytosis in macrophages or epithelial cells is present only 
for a few minutes after growth factor stimulation, it is con- 
stitutive in DCs since it is present even days after removal 
of GM-CSF and IL-4 and can be detected in fresh veiled cells 
ex vivo.  Our results are in apparent contrast with previous 
studies in which DCs have been shown to have a detectable 
but rather low level of endocytosis (21, 22). This discrepancy 
may be explained by the fact that different cell populations 
have been analyzed in these studies.  It is well known that 
DC can change their properties after maturation and lose an- 
tigen capturing capacity (references 6, 8 and this study). The 
cells from GM-CSF  +  IL-4 cultures may be the equivalent 
of immature DCs, a stage that is difficult to preserve ex vivo 
or in different culture conditions. 
How can macrosolutes be concentrated in DCs? The for- 
mation and fate of macropinosomes differs in different cell 
types. In epithelial cells stimulated by epidermal growth factor, 
the pinosomes do not fuse with intracellular vesicles, but only 
among themselves, and recycle back within 20-30 min (13). 
In contrast, in macrophages stimulated by macrophage-CSF 
(23) and in DCs, the macropinosomes mature and go on to 
fuse with a lysosomal compartment. In the latter case, the 
vesicles that recycle back from this compartment to the cell 
surface are much smaller than the macropinosomes and thus 
will recycle much more membrane than fluid (24). This im- 
balance causes shrinkage of the compartment, loss of water 
and permeable compounds, and concentration of the macro- 
solutes. 
The fate of the molecules taken up by macropinocytosis 
depends on their physical and chemical properties.  Membrane- 
permeable compounds will passively diffuse out, while im- 
permeable compounds such as sucrose (25), LY, or FITC-DX 
will accumulate. In steady-state conditions protein antigens 
that are delivered to this compartment will be continuously 
eliminated by degradation into peptides and subsequently into 
permeable amino acids (26). Peptides carrying the appropriate 
motifs may be rescued by MHC class II molecules and trans- 
ported to the cell surface, where they will effectively accumulate 
as long lived complexes (27).  In this context, the very high 
level of class II synthesis (up to 10-fold that of EBV-B cells; 
Sallusto,  F.,  unpublished data) is an important attribute of 
DCs  as it  endows them with powerful peptide  sampling 
capacity. 
The very high level of macropinocytosis may have impor- 
tant consequences for the traffic of surface molecules. Indeed, 
while in all cell types surface molecules are internalized via 
coated pits that act as molecular filters,  in DCs all surface 
molecules must be internalized primarily via macropinocy- 
tosis, which is expected to be nonselective. Thus, this alter- 
native pathway will allow molecules that are usually excluded 
from coated pits to be internalized at high rate,  a fact that 
may have functional consequences in the case of MHC class 
I and II molecules as discussed below. 
The MHC Class II Compartment in DCs.  We have shown 
that DCs generated in culture with GM-CSF and IL-4 are 
characterized by the presence of a large intracellular compart- 
ment that contains class II molecules, cathepsin D, and Lamp-l, 
and is rapidly accessible to endocytic markers. It is not clear 
how this compartment relates to the MHC class II compart- 
ment  described in  EBV-B  cells  and  other class  II §  cells 
(28-32).  Specifically, it will need to be established whether 
the class II molecules in this compartment are derived only 
from the biosynthetic pathway or also from mature cell sur- 
face molecules taken up via macropinocytosis. Thus, while 
in B cells mature surface class II molecules are internalized 
only to a very small extent and recycle through early endo- 
somes and thus do not reenter the compartment where an- 
tigen processing occurs (33,  34), it is possible  that in DCs 
mature class II molecules may be internalized at high rates 
via macropinocytosis into this compartment and recycle back 
to the cell surface. It will be important to establish  whether 
empty cell surface class II molecules may be efficiently inter- 
nalized and loaded with peptide from processed antigen in 
DCs. It is interesting that the kinetics of antigen processing 
in DCs is much faster than in antigen-specific B cells (35), 
suggesting that the trafficking of antigen and class II mole- 
cules may be different in these two cells types (Sallusto,  F., 
unpublished data). 
Induction of DC Maturation In Vitro.  A breakthrough in 
understanding the function of DCs has been the identification 
of two stages of maturation (6). According to this scheme, 
immature DCs residing in nonlymphoid tissues take up and 
process antigen and migrate to the regional lymph nodes, 
where they arrive as mature DCs that have lost antigen cap- 
turing and processing capacity and that have gained increased 
T  cell stimulatory capacity (7, 8). The nature of the signal 
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clear, although there is some evidence that TNF-c~ may have 
an important role (36-39). 
We have used DCs generated in culture with GM-CSF 
and IL-4 as a model of immature DCs to identify the signals 
that may induce their maturation. We have found that DCs 
respond not only to TNF-ot, but also to CD40L, IL-1, and 
LPS with a coordinate series of changes that include a com- 
plete downregulation of macropinocytosis and a disappear- 
ance of the class II compartment, concomitant with an up- 
regulation of adhesion and costimulatory molecules. These 
changes occur within 24-48 h and are irreversible,  since the 
immature phenotype is not recovered when the maturation- 
inducing stimulus is removed. Interestingly, the uptake of 
HRP and FITC-DX is downregulated to a much higher ex- 
tent than the surface MR, which is only partially downregu- 
lated. This discrepancy suggests that in immature DCs, mac- 
ropinocytosis may be the major pathway of internalization 
of the MR. 
The complex changes in DCs best serve their physiolog- 
ical function. The upregulation of CD44V expression (9) and 
possibly downregulation of  E-cadherin (40) may change their 
migratory properties. The reduction of pinocytosis, the down- 
regulation of MR, and the loss of the class II compartment 
result in "freezing" the cell into the presentation of the anti- 
gen that was present at the time of contact with the matura- 
tion inducing signal.  Finally, the increase  in adhesion and 
costimulatory  molecules will facilitate priming of naive T cells. 
It is tempting to speculate that the capacity of DCs to re- 
spond with these changes to inflammatory cytokines or ex- 
ogenous bacterial products might have developed to favor the 
earliest possible recognition of invading pathogens, since pre- 
sentation of antigens from dangerous pathogens will be fa- 
vored compared to presentation of nondangerous self antigens 
(41, 42). The identification of substances that induce DC matu- 
ration and modulate their function may help to understand 
the regulation of antigen presentation in physiological and 
pathological situations and may lead to the design of more 
effective adjuvants. 
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